Scientific Literature Search

Source record

Cerebrotendinous Xanthomatosis: Clinical Features of Affected Individuals From Latin America.

Martínez-Hernández HR, Villa-Villegas L, Piña-Avilés CE, Leal-Ortega R, Sáenz-Farret M, Camacho-Molina A, Zúñiga-Ramírez C.

Neurol Genet · 2026-10-09

DOI: 10.1212/nxg.0000000000200443PMID: 42924165

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Clinical and Electrophysiological Heterogeneity of Orthostatic Tremor: An Individual Patient Data Analysis.

D'Souza L, Niharika BR, Benito-León J, Samarth BR, Das R, Kotwal M, Reddy K, Katti PA, Bhat CSP.

Tremor Other Hyperkinet Mov (N Y) · 2026-10-08

DOI: 10.5334/tohm.1278PMID: 42857721

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Building Scalable Recruitment Models for Precision Medicine in Parkinson's Disease: Insights from GBA1 Trials.

Corvol JC, Tesson C, Liot S, Carvalho S, Castelnovo G, Damier P, Defebvre L, Giordana C, Houeto JL, Marques A, Meissner WG, Remy P, Thobois S, Fabbri M, Rascol O, NS‐PARK cohort.

Mov Disord · 2026-10-08

DOI: 10.1002/mds.70537PMID: 42845097

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

The Gut-Brain Axis in Parkinson's Disease: From Clinical Observation toward Mechanism-Based Precision Medicine.

Scheperjans F, Borghammer P, Pfeiffer RF, Appel-Cresswell S, Keshavarzian A.

Mov Disord · 2026-10-08

DOI: 10.1002/mds.70566PMID: 42845110

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations.

Schneider RB, Skibinski G, Fiske B, Kopil CM, Merchant K, Simuni T.

J Parkinsons Dis · 2026-10-08

DOI: 10.1177/1877718x261493297PMID: 42847638

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial.

Brakedal B, Skeie GO, Derad C, Alstadhaug KB, Anundskås I, Berven H, Biermann M, Bjørnarå KA, Torres Cleuren YN, Dalbro SEJ, Eidelberg D, Foldnes K, Fortes G, Haugarvoll K, Herlofson K, Hustad E, HogenEsch RI, Johanson GAS, Johnsen SH, Kunszt K, Kverneng S, Labusau A, Lie IH, Lilleng H, Lundervold K, Lundqvist C, Ma Y, McCann A, Njølstad TH, Pihlstrøm L, Riemer F, Rognerud AK, Sheard E, Simonsen AM, Storm E, Svensen M, Toker L, Tunold JA, Dölle C, Friede T, Tzoulis C.

JAMA · 2026-10-08

DOI: 10.1001/jama.2026.18828PMID: 42848371

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

The Braak Paradox: When Parkinson Pathology and Clinical Progression Disconnect.

Rodríguez-Violante M.

Neurology · 2026-10-08

DOI: 10.1212/wnl.0000000000218535PMID: 42848965

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Relationship Between Braak and Clinical Stage in Autopsy-Confirmed Parkinson Disease: A UK Brain Bank Study.

di Biase L, Pecoraro PM, Bugamelli F, Di Carluccio M, Marsili L, Espay AJ.

Neurology · 2026-10-08

DOI: 10.1212/wnl.0000000000218469PMID: 42848968

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

A novel oxidative-inflammatory biomarker for Parkinson's disease: clinical utility of the uric acid-to-albumin ratio.

Xiu W, Zhang G, Chen Y, Sun C, Gao Y, Li A, Zhang H, Shuai P, Cheng J, Wang J, Xiao X, Deng B.

Neurol Sci · 2026-10-07

DOI: 10.1007/s10072-026-09415-4PMID: 42839150

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

KCNA2-Associated Hereditary Spastic Paraplegia: Clinical Characteristics and Rationale for Targeted Treatment.

Boßelmann CM, Vyhnalek M, Blichova Z, Novotna L, Meszarosova AU, Havránková P, Kuster E, Lauerer RJ, Hedrich UBS, Lyu H, Oosterloo M, Alber M, Schöls L, Müller-Schlüter K, Bischoff AT, Klopstock T, Koutsis G, Karadima G, Efthymiou S, Houlden H, Salazar-Villacorta A, Ellis CA, Scheper A, Gläser D, Haack TB, Wagner M, Zech M, Platzer K, Striano P, Syrbe S, Schüle R, Lerche H.

Mov Disord · 2026-10-07

DOI: 10.1002/mds.70555PMID: 42844944

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Efficacy and Safety of Safinamide as an Adjunct to Levodopa for Motor Fluctuations in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Ahmed AAO, Ahmed OAO, Dishean AS, Gilbert C, Elkheir MMAS, Sota HA, Abdulaziz MAM, Mahmoud EYM, Ahmed RAO.

Parkinsons Dis · 2026-10-06

DOI: 10.1155/padi/9352886PMID: 42846716

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Rotigotine transdermal patch in Parkinson's disease: a narrative review of pharmacology, clinical evidence, special-population management, and health economics.

Sun X, Qian D, Zhao W, Zhang J, Hu X, Zhang Y.

Front Pharmacol · 2026-10-06

DOI: 10.3389/fphar.2026.1933610PMID: 42903465

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

7.691 articles found

Cerebrotendinous Xanthomatosis: Clinical Features of Affected Individuals From Latin America.

Clinical and Electrophysiological Heterogeneity of Orthostatic Tremor: An Individual Patient Data Analysis.

Building Scalable Recruitment Models for Precision Medicine in Parkinson's Disease: Insights from GBA1 Trials.

The Gut-Brain Axis in Parkinson's Disease: From Clinical Observation toward Mechanism-Based Precision Medicine.

Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations.

Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial.

The Braak Paradox: When Parkinson Pathology and Clinical Progression Disconnect.

Relationship Between Braak and Clinical Stage in Autopsy-Confirmed Parkinson Disease: A UK Brain Bank Study.

A novel oxidative-inflammatory biomarker for Parkinson's disease: clinical utility of the uric acid-to-albumin ratio.

KCNA2-Associated Hereditary Spastic Paraplegia: Clinical Characteristics and Rationale for Targeted Treatment.

Efficacy and Safety of Safinamide as an Adjunct to Levodopa for Motor Fluctuations in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Rotigotine transdermal patch in Parkinson's disease: a narrative review of pharmacology, clinical evidence, special-population management, and health economics.

Filters